COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,879 Articles (22,568 medRxiv, 8,311 bioRxiv)

Most recent first Previous |  Page 735: Articles 7341-7350  | Next

Modeling suggests that multiple immunizations or infections will reveal the benefits of updating SARS-CoV-2 vaccines
Desikan, R., Linderman, S. L., Davis, C. W., Zarnitsyna, V. I., Ahmed, H. R., Antia, R.
10.1101/2022.05.21.492928 — Posted: 2022-05-23
Variant-specific symptoms of COVID-19 among 1,542,510 people in England
Whitaker, M., Elliott, J., Bodinier, B., Barclay, W. S., Ward, H., Cooke, G., Donnelly, C. A., Chadeau-Hyam, M., Elliott, P.
10.1101/2022.05.21.22275368 — Posted: 2022-05-23
Patient satisfaction with telemedicine in the Philippines during the COVID-19 pandemic
Noceda, A. V. G., Acierto, L. M. M., Bertiz, M. C. C., Dionisio, D. E. H., Laurito, C. B. L., Sanchez, G. A. T., Amit, A. M. L.
10.1101/2022.05.21.22274939 — Posted: 2022-05-23
Safety of the BNT162b2 mRNA COVID-19 Vaccine in Children below 5 Years in Germany (CoVacU5): An Investigator-initiated Retrospective Cohort Study
Toepfner, N., von Meissner, W. C. G., Strumann, C., Drinka, D., Stuppe, D., Jorczyk, M., Moor, J., Pueschel, J., Liss, M., von Poblotzki, E., Berner, R., Moor, M. B., Chao, C.-M.
10.1101/2022.05.17.22275005 — Posted: 2022-05-23
COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022
Marquez, C., Kerkhoff, A., Schrom, J., Rojas, S., Black, D., Mitchell, A., Wang, C.-Y., Pilarowski, G., Ribeiro, S., Jones, D., Payan, J., Manganelli, S., Rojas, S., Lemus, J., Jain, V., Chamie, G., Tulier-Laiwa, V., Petersen, M., DeRisi, J., Havlir, D.
10.1101/2022.05.19.22274968 — Posted: 2022-05-23
A Mesoscale Agent Based Modeling Framework For Flow-mediated Infection Transmission In Indoor Occupied Spaces
Mukherjee, D., Wadhwa, G.
10.1101/2022.05.20.22275409 — Posted: 2022-05-23
Low testing rates limit the ability of genomic surveillance programs to monitor SARS-CoV-2 variants: a mathematical modelling study
Han, A. X., Toporowski, A., Sacks, J. A., Perkins, M., Briand, S., van Kerkhove, M., Hannay, E., Carmona, S., Rodriguez, B., Parker, E., Nichols, B. E., Russell, C. A.
10.1101/2022.05.20.22275319 — Posted: 2022-05-23
Machine Learning for Identifying Data-Driven Subphenotypes of Incident Post-Acute SARS-CoV-2 Infection Conditions with Large Scale Electronic Health Records: Findings from the RECOVER Initiative
Zhang, H., ZANG, C., Xu, Z., Zhang, Y., Xu, J., Bian, J., Morozyuk, D., Khullar, D., Zhang, Y., Nordvig, A. S., Schenck, E. J., Shenkman, E. A., Rothman, R. L., Block, J. P., Lyman, K., Weiner, M., Carton, T. W., Wang, F., Kaushal, R.
10.1101/2022.05.21.22275412 — Posted: 2022-05-23
Omicron and vaccines: An analysis on the decline in COVID-19 mortality
Larrauri, B., Malbran, A., Larrauri, J. A.
10.1101/2022.05.20.22275396 — Posted: 2022-05-23
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform
Zheng, B., Green, A. C., Tazare, J., Curtis, H. J., Fisher, L., Nab, L., Schultze, A., Mahalingasivam, V., Parker, E., Hulme, W. J., Bacon, S. C., DeVito, N. J., Bates, C., Evans, D., Inglesby, P., Drysdale, H., Davy, S., Cockburn, J., Morton, C. E., Hickman, G., Ward, T., Smith, R. M., Parry, J., Hester, F., Harper, S., Mehrkar, A., Eggo, R. M., Walker, A. J., Evans, S. J., Douglas, I. J., MacKenna, B., Goldacre, B., Tomlinson, L. A.
10.1101/2022.05.22.22275417 — Posted: 2022-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).